Clinical and experimental rheumatology
Giant cell arteritis in clinical practice: beyond GiACTA.
Francesca Regola, Jacopo Mora, Matteo Riva, Giulia Fontana, Alessia Gatti, Ilaria Cavazzana, Franco Franceschini, Paola Toniati
Published: 202510.55563/clinexprheumatol/7vcti0
Abstract
OBJECTIVES: Giant cell arteritis (GCA) therapy relies on high-dose glucocorticoids (GCs), which are associated with a high incidence of side effects and GCA relapses, highlighting the need for steroid-sparing agents such as tocilizumab (TCZ) and meth…
Preview only. Read the full abstract at the source